Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Butler

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitorsAesop Cho, Lijun Zhang, Jie Xu, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
A novel hereditary encephalopathy in four related Labrador Retrievers associated with a missense variant in the ALDH5A1 geneEllen Schofield, Thomas Butler, Rita Gonçalves, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Bismuth Quadruple Therapy with Doxycycline Is an Effective First-Line Therapy for <i>Helicobacter pylori</i> in an Irish CohortConor Costigan, Mark Comerford, Ronan Whitmarsh, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A proteaseX Christopher Sheng, Todd Appleby, Thomas Butler, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patientsAesop Cho, Lijun Zhang, Jie Xu, et al.
Nature Biotechnology|October 11, 2008
The potential and challenges of nanopore sequencingDaniel Branton, David W Deamer, Andre Marziali, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
World Journal of Gastroenterology|February 16, 2026
Lack of follow-up in <i>Helicobacter pylori</i> eradication treatment: Results from the European registry on <i>Helicobacter pylori</i> managementElisa Cantú-Germano, Leticia Moreira, Ángeles Pérez-Aisa, et al.
Neurology|January 27, 2026
Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in AdultsCarolina Ferreira-Atuesta, Jane De Tisi, Andrew William Mcevoy, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitorsAesop Cho, Lijun Zhang, Jie Xu, et al.
Journal of Veterinary Internal Medicine|February 26, 2026
A novel hereditary encephalopathy in four related Labrador Retrievers associated with a missense variant in the ALDH5A1 geneEllen Schofield, Thomas Butler, Rita Gonçalves, et al.
Antibiotics (Basel, Switzerland)|August 28, 2025
Bismuth Quadruple Therapy with Doxycycline Is an Effective First-Line Therapy for <i>Helicobacter pylori</i> in an Irish CohortConor Costigan, Mark Comerford, Ronan Whitmarsh, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A proteaseX Christopher Sheng, Todd Appleby, Thomas Butler, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patientsAesop Cho, Lijun Zhang, Jie Xu, et al.
Nature Biotechnology|October 11, 2008
The potential and challenges of nanopore sequencingDaniel Branton, David W Deamer, Andre Marziali, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
World Journal of Gastroenterology|February 16, 2026
Lack of follow-up in <i>Helicobacter pylori</i> eradication treatment: Results from the European registry on <i>Helicobacter pylori</i> managementElisa Cantú-Germano, Leticia Moreira, Ángeles Pérez-Aisa, et al.
Neurology|January 27, 2026
Timing for Starting Antiseizure Medication Withdrawal After Epilepsy Surgery in AdultsCarolina Ferreira-Atuesta, Jane De Tisi, Andrew William Mcevoy, et al.
Pageof 7